Abstract: In some implementations, a device may obtain telemetry data associated with the cloud computing environment, wherein the telemetry data indicates one or more processing parameters of an application deployed in the cloud computing environment via a current virtualized node. The device may determine, for the application, a processing capacity utilization score of the application. The device may determine, based on the processing capacity utilization score and the one or more processing parameters, one or more recommended virtualized nodes from one or more virtualized nodes associated with the cloud computing environment. The device may perform an action associated with a selection of an operating virtualized node for the application from the current virtualized node and the one or more recommended virtualized nodes.

Abstract: A method includes in part, generating an electro-optical frequency map (EOFM) of an active layer of an integrated circuit (IC), retrieving a reference map of the IC, comparing the EOFM of the IC with the reference map to determine whether there is a match between an intensity of an identified region in the EOFM map and an intensity of a corresponding region of the reference map, and detecting one or more hardware trojans in the IC if there is no match. The reference map may be associated with a layout of an IC known not to include hardware trojans. The reference map also may be a second EOFM associated with the IC. Alternatively, the reference map may be generated by applying power to the IC, and applying a clock signal to the IC.

Abstract: A method includes in part, generating an electro-optical frequency map (EOFM) of an active layer of an integrated circuit (IC), retrieving a reference map of the IC, comparing the EOFM of the IC with the reference map to determine whether there is a match between an intensity of an identified region in the EOFM map and an intensity of a corresponding region of the reference map, and detecting one or more hardware trojans in the IC if there is no match. The reference map may be associated with a layout of an IC known not to include hardware trojans. The reference map also may be a second EOFM associated with the IC. Alternatively, the reference map may be generated by applying power to the IC, and applying a clock signal to the IC.

Abstract: In at least one aspect, a water-sports board is configured to collect environmental data. The water-sports board includes a waterproof sensor housing and, disposed within the housing, one or more sensor(s), processor(s), memory device(s), switch(es), batteries. The sensing device is configured, in a first state, not to store environmental data sensed by the at least one sensor in the at least one physical memory device. The sensing device is configured, in a second state, to store environmental data sensed by the at least one sensor in the at least one physical memory device.

Abstract: The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof:

Abstract: In at least one aspect, a water-sports board is configured to collect environmental data. The water-sports board includes a waterproof sensor housing and, disposed within the housing, one or more sensor(s), processor(s), memory device(s), switch(es), batteries. The sensing device is configured, in a first state, not to store environmental data sensed by the at least one sensor in the at least one physical memory device. The sensing device is configured, in a second state, to store environmental data sensed by the at least one sensor in the at least one physical memory device.

Abstract: The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof:

Abstract: The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof:

Abstract: The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof:

Abstract: The invention provides compositions and methods for the detection of biological targets, (e.g. nucleic acids and proteins) by nucleic acid templated chemistry, for example, by generating fluorescent, chemiluminescent and/or chromophoric signals.

Abstract: A thrombin receptor antagonist having the formula useful for inhibiting the aggregation of blood platelets. The compounds can be used in a method of acting upon a thrombin receptor which comprises administering a therapeutically effective but non-toxic amount of such compound to a mammal, preferably a human.

Abstract: A thrombin receptor antagonist having the formula 1